Skip to main content
Clinical Trials/NCT01461902
NCT01461902
Completed
Not Applicable

Measuring Vasospasm, Biomarkers, and Neurocognitive Outcomes in Pediatric Traumatic Brain Injury

Duke University1 site in 1 country6 target enrollmentSeptember 2011
ConditionsBrain Injury

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injury
Sponsor
Duke University
Enrollment
6
Locations
1
Primary Endpoint
Vasospasm detection by Transcranial Doppler Ultrasound
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to assess for vasospasm using Transcranial Doppler (TCD) and brain injury biomarkers, and evaluate neurocognitive outcome data in pediatric traumatic brain injury (TBI) patients who have experienced a mild to severe head injury.

Registry
clinicaltrials.gov
Start Date
September 2011
End Date
December 2013
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • admission to Duke University Children's Hospital;
  • age 5 days to 15 years;
  • a diagnosis of a TBI with a GCS 3-15;
  • capable of adequate TCD ultrasound examination;
  • and presence of intravenous or arterial access (blood) and/or an EVD for cerebrospinal fluid (CSF) and/or Foley catheter/ability to void unassisted (urine) biomarker collection unless they are excluded based on the exclusion criteria.

Exclusion Criteria

  • the presence of previously diagnosed significant neurodevelopmental delay,
  • a diagnosis of non-traumatic intracranial hemorrhage and
  • parents/legal guardians who do not speak or understand English.

Outcomes

Primary Outcomes

Vasospasm detection by Transcranial Doppler Ultrasound

Time Frame: 8 days

Daily transcranial doppler ultrasound performed in pediatric traumatic head injury patients.

Secondary Outcomes

  • Detection of biomarkers in pediatric traumatic brain injury(2 days)

Study Sites (1)

Loading locations...

Similar Trials